Preiss, D. and Sattar, N. (2011) The case for diabetes screening: ADDITION-Europe. Lancet, 378(9786), pp. 106-108. (doi: 10.1016/S0140-6736(11)60819-2)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1016/S0140-6736(11)60819-2
Abstract
In The Lancet , Simon Griffin and colleagues report findings from the ADDITION-Europe study, which compared intensive multifactorial therapy with routine care according to national guidelines for patients with type 2 diabetes detected by screening. The aim was to reduce major cardiovascular events. Although only a small trend towards cardiovascular benefit from intensive treatment compared with routine care was recorded, some other aspects of the trial have important messages.
| Item Type: | Articles (Editorial) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Preiss, Dr David and Sattar, Professor Naveed |
| Authors: | Preiss, D., and Sattar, N. |
| Subjects: | R Medicine > R Medicine (General) |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Lancet |
| Publisher: | The Lancet Publishing Group |
| ISSN: | 0140-6736 |
| ISSN (Online): | 1474-547X |
University Staff: Request a correction | Enlighten Editors: Update this record
Altmetric
Altmetric